supertramp, your post in its entirety, is not a truthful statement. Line 1: True....they are unknown to us Biotecs and anyone interested in business success. Line 2: False...the current BOD and Management team pulled the lost cause TIS out of the waste bin and revived it. The subsequent great loss of SH wealth occurred simply because the Clinical Trial failed. That failure was something no BOD could have caused to happen. It was the result of a well run Trial, and as was proven, a rather weak and/or dodgy product. Line 3: A bit of both True & False.....Yours is an opinion, so in return, here is mine. I do not believe the WA team has all shareholders interests at heart, only their own interests seem matter to them. Whereas the current BOD are at least giving us the opportunity for success a good go. My support is with the current BOD.
FTT Price at posting:
0.4¢ Sentiment: Hold Disclosure: Held
